患有急性冠状动脉综合征的患者缺血性心血管结果的风险预测模型
Qi Zhang1,2,3,4, Jie Gao1,2,3,4, Xiaoying Yin1,2,3,4
1Department of Emergency Medicine, Qilu Hospital of Shandong University, 250012 Jinan, Shandong, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
急性冠状动脉综合征 (ACS) 患者需要进行风险评估,以提高生存率. 临床风险评分有助于预测预后,并指导有效的及时治疗,以预防不良心血管事件.
科学领域:
- 心脏病学 心脏病学
- 临床风险评估临床风险评估
- 预防医学 预防医学
背景情况:
- 急性冠状动脉综合征 (ACS) 经常导致不良心血管事件,即使有早期干预.
- 患有ACS的患者在出院后往往面临着不良的预后,这凸显了需要改进的长期管理策略的需要.
研究的目的:
- 审查现有的风险评分,以预测ACS患者的死亡率和缺血事件.
- 强调风险分层在为ACS幸存者量身定制治疗计划时的重要性.
主要方法:
- 对ACS临床风险预测模型的文献综述.
- 对与患者结局 (死亡率,缺血事件) 相关的风险得分研究的分析.
主要成果:
- 风险评估模型对于识别高风险ACS患者至关重要.
- 临床风险得分能够准确评估预后和个性化治疗策略.
结论:
- 使用验证得分的有效风险分层对于改善ACS患者的长期存活率至关重要.
- 在风险评估的指导下,及时和适当的治疗可以减轻短期和长期的心血管风险.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.3K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.4K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
128
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
128
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69